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Abstract 
Loss of IFNB/interferon-in mice causes a Parkinson disease-like phenotype where many 
features, including SNCA/-synuclein and MAPT/tau accumulation, can be attributed to a 
late-stage block in autophagic flux. Recently, we identified a mechanism that can explain 
this phenotype. We found that IFNB induces expression of Mir1, a microRNA that can 
reduce the levels of TBC1D15, a RAB GTPase-activating protein. Induction of this pathway 
decreases RAB7 activity and thereby stimulates macroautophagy/autophagy. The 
relevance of these key players is deeply conserved from humans to Caenorhabditis elegans, 

















Autophagy is a pathway that enables degradation of cytoplasmic contents by 
wrapping them within double-layered vesicles called autophagosomes. These 
autophagosomes fuse with lysosomes, which facilitates degradation of their lumenal 
contents. The transport and fusion steps are governed by numerous proteins, including RAB 
GTPases, such as RAB7, HOPS and SNARE proteins. 
 The accumulation of neurotoxic aggregation-prone proteins is a hallmark of many 
age-related neurodegenerative diseases, such as Parkinson disease, Alzheimer disease, 
Huntington disease, and amyotrophic lateral sclerosis. Mendelian mutations associated with 
many neurodegenerative diseases compromise autophagy, and these potentiate the 
accumulation of various aggregate-prone proteins, because such proteins, including mutant 
HTT (huntingtin), MAPT/tau and SNCA/-synuclein, are autophagic substrates. Autophagy 
is particularly important for the degradation of oligomeric and higher-order assemblies that 
characterize these neurodegenerative disease-causing proteins, as these are inaccessible 
to the proteasome, or chaperone-mediated autophagy.  
 Previously, we reported that mice lacking the Ifnb1 (interferon beta 1, fibroblast) gene, 
an essential cytokine in anti-viral immune responses and T-cell regulation, develop a 
phenotype resembling Parkinson disease with the accumulation of intraneuronal SNCA and 
MAPT aggregates, and loss of dopaminergic neurons, associated with cognitive and motor 
disturbances. We found that lack of IFNB input causes a late-stage block in neuronal 
autophagy compatible with impaired autophagosome degradation. Conversely, treatment 
with recombinant IFNB promotes autophagy flux, and coherently we demonstrated that in 
vivo brain expression of Ifnb reduces SNCA-induced neurotoxicity in a rat model of 
Parkinson disease. However, it was not clear how IFNBregulates autophagy. 
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 Recently, we identified a mechanism explaining how IFNB influences autophagy by 
focussing our studies on the microRNA, mir-1, which is depleted in a Drosophila 
melanogaster model of Alzheimer disease, and MIR1, which is reduced in the cerebrospinal 
fluid of patients with Parkinson disease [1]. microRNAs rapidly downregulate translation of 
multiple target genes by imperfect binding to motifs in their 3' UTR region. MIR1 is a highly 
conserved miRNA and despite 600 million years of evolutionary distance, the sequence of 
the miR-1/MIR1 seed region is fully conserved in worms and humans. Thus, we made use 
of a C. elegans in vivo model to ectopically express an aggregation-prone fragment of 
mutant HTT (HTTQ40), which causes Huntington disease-like pathology. Loss of mir-1 leads 
to the formation of significantly more HTTQ40 protein aggregates when compared to the wild-
type worms, and expressing wild-type mir-1 in mutant worms reduces the aggregation 
burden. Similarly, loss of mir-1 in worms enhances exogenous SNCA aggregate formation 
and causes behavioral abnormalities. These defects are associated with our finding that mir-
1 is a positive autophagy regulator.  
 Consistent with the worm data, we found that overexpression of MIR1 decreases 
mutant HTT exon 1 aggregation in HeLa cells, and this could be attributed to enhanced 
autophagic flux. From the TargetScan database we identified human TBC1D15 (TBC1 
domain family member 15) and a C. elegans homolog TBC-7 as potential targets of 
MIR1/mir-1, both of which are putative negative regulators of autophagy. These proteins are 
RAB-GTPase activating proteins (GAPs), which promote termination signalling of RAB 
GTPases, and TBC1D15 targets RAB7, a known regulator of autophagy. Thus, we tested 
and confirmed that TBC1D15/TBC-7 is a genuine target of MIR1/mir-1 using C. elegans- 
and human-specific reagents. For example, MIR1 targets the 3' UTR of TBC1D15 in HeLa 
cells and consequently reduces the amount of TBC1D15 protein.  
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 Next, we investigated how TBC1D15 influences autophagy flux. Overexpression of 
TBC1D15 in HeLa cells causes a late-stage block in autophagy compatible with defective 
autophagosome degradation, and TBC1D15 knockdown mimics the autophagy induction 
observed with MIR1 overexpression. The increase of autophagy induced by MIR1 is blocked 
by overexpression of TBC1D15 that lacks the endogenous 3' target sequence for MIR1. 
Finally, we showed that RAB7 is indeed a target of TBC1D15, as overexpression of 
TBC1D15 significantly reduces the amount of active GTP-bound RAB7. As expected, loss 
of RAB7 leads to a late-stage block in autophagy, and co-expression of a constitutive active 
RAB7Q67L mutant counteracts the TBC1D15-mediated autophagy block. 
 A previous study observed that IFNB regulates MIR1 in hepatic cells. This provided 
the clue and impetus to test whether this cytokine could regulate autophagy and aggregate-
prone protein clearance via the MIR1-TBC1D15-RAB7 pathway. We found that IFNB 
upregulates Mir1 while reducing the amount of TBC1D15 protein in primary cortical neuron 
cultures from mice, and in HeLa cells, where the effect of the cytokine on TBC1D15 levels 
depends on the presence of an intact 3' UTR MIR1 binding site. The effects of IFNB on 
autophagic flux and mutant HTT accumulation depend on MIR1 and TBC1D15, as they are 
abrogated by a MIR1 hairpin inhibitor or TBC1D15 overexpression.  
 Collectively, our data provide new mechanistic insight into how IFNB promotes 
autophagy via MIR1-TBC1D15-RAB7, thereby limiting accumulation of aggregation-prone 
proteins such as SNCA and HTT (Figure 1). The deep evolutionary conservation from worm 
to human emphasizes the biological importance of MIR1, and it will be interesting to explore 
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Figure 1. Schematic overview. (A) IFNB binds to IFNAR1/IFN-/-receptor and activates 
downstream signaling (1) including transcription of MIR1 (2), which binds to the 3' UTR of 
TBC1D15 and thereby repress its translation (3). TBC1D15 is a GTPase activating protein 
(GAP), which shuts down the activity of RAB7 by promoting GDP-binding. Thus, with low 
levels of TBC1D15, the abundance of active GTP-bound RAB7 will be favored due to 
guanine nucleotide exchange factor (GEF) activity (4). Protein aggregates are targeted by 
autophagy cargo receptors and subsequently couple to LC3-II in the phagophore membrane 
(5), which eventually forms a vesicular autophagosome (6). The autophagosomes fuse with 
lysosomes for clearance of the protein aggregates in a process promoted by active RAB7 
(7). (B) If TBC1D15 translation is increased, e.g., by low MIR1 (8) this shuts down RAB7 
activity (9), and under stress conditions neurotoxic protein aggregates will form due to 
reduced autophagy (10).  
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